News
The deal “fits like a glove” for BioMarin’s business, according to an analyst who also thinks there could be a “valuable” ...
A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and ...
Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have lost more than half their value over the past 12 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results